﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Maad Rayan Publishing Company</PublisherName>
      <JournalTitle>Biomedicine Advances</JournalTitle>
      <Issn>3080-0382</Issn>
      <Volume>3</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2026</Year>
        <Month>07</Month>
        <DAY>30</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Cardiac Patch as a Superior Clinically Translatable Approach for Cardiac Regenerative Medicine</ArticleTitle>
    <FirstPage>87</FirstPage>
    <LastPage>88</LastPage>
    <ELocationID EIdType="doi">10.34172/bma.85</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Sara</FirstName>
        <LastName>Pahlavan</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-8854-2626</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>EDITORIAL</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/bma.85</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2026</Year>
        <Month>05</Month>
        <Day>02</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2026</Year>
        <Month>06</Month>
        <Day>10</Day>
      </PubDate>
    </History>
    <Abstract>Author’s Biosketch Sara Pahlavan is a member of Cardiovascular Group at Royan Institute for Stem Cell Biology and Technology. She studied Biology in her B.Sc and graduated in M.Sc of Physiology from Shiraz University. During her undergraduate studies, she got interested in physiology of cardiac cells, specifically excitation-contraction coupling. To pursue her interest, she moved to Germany and started her graduate studies in Professor Peter Lipp’s lab at Universitäts Klinikum des Saarlandes. There, she learned state of the art technologies such as simultaneous "patch-clamp" and "Ca2+ imaging" to study excitation-contraction coupling in cardiomyocytes. Furthermore, she used transgenic mice to study pathophysiology of inherited cardiac diseases with respect to electrophysiology and/or Ca2+ machinery. Toward the end of her PhD studies, she got interested in using patient-specific iPSC-derived cardiomyocytes to study cardiac disease in human cardiac cells and to test new drugs. To pursue this goal, she moved to United States and started her postdoctoral fellowship in Professor Martin Morad’s lab at Medical University of South Carolina. There she could develop a new genetically-encoded Ca2+ probe to study Ca2+ induced Ca2+ release and Ca2+ sparks in cardiomyocytes of healthy and patient-specific iPSC-derived cardiomyocytes. She joined Royan Institute at 2015 and currently she works as an Associate Professor in cardiovascular Group.</Abstract>
  </Article>
</ArticleSet>